Identification of Actionable Gene Variants in Pulmonary Large-Cell Neuroendocrine Carcinoma: A Real-World Analysis of a Polish Cohort肺大细胞神经内分泌癌中可操作基因变异的鉴定:一项波兰队列的真实世界分析International Journal of Molecular SciencesIF4.92026-03-300OAAI
Targeted RNA-based next-generation sequencing as a robust diagnostic tool for non-small cell lung cancer genetic testingEUROPEAN RESPIRATORY JOURNALIF212024-10-300PRE
Gene expression and mutational profiling of NSCLC in relation to KRAS G12CEUROPEAN RESPIRATORY JOURNALIF212024-10-300PRE
Improved detection of druggable EGFR variants in non-small cell lung cancer using targeted next-generation sequencingEUROPEAN RESPIRATORY JOURNALIF212024-10-300PRE
Plasma inflammatory proteins and transcriptome profiles of neutrophils in COPD patients with PiMM and PiZZ alpha1antitrypsin treated or non-treated with augmentation therapyEUROPEAN RESPIRATORY JOURNALIF212023-10-270PRE
Thymic epithelial tumours present the number of known and novel gene variants in molecular analysis using targeted next-generation sequencingEUROPEAN RESPIRATORY JOURNALIF212023-10-270PRE
The predictive value of circulating tumor DNA dynamics in plasma of EGFR-mutation-positive NSCLC patients on first line tyrosine kinase inhibitorsEUROPEAN RESPIRATORY JOURNALIF212021-11-250PRE
Dynamic monitoring of EGFR mutations in circulating tumor DNA for early detection of drug resistance in NSCLC patients on EGFR-TKI therapyEUROPEAN RESPIRATORY JOURNALIF212019-11-210PRE
The EGFR mutation detection in NSCLC by Next Generation Sequencing (NGS): cons and prosEUROPEAN RESPIRATORY JOURNALIF212019-11-211PRE
The selection of candidate microRNA biomarkers of acquired drug resistance in the lung adenocarcinoma cells treated with EGFR TKIEUROPEAN RESPIRATORY JOURNALIF212019-11-210PRE
The expression of circulating miR-504 in plasma is associated with EGFR mutation status in non-small-cell lung carcinoma patientsCELLULAR AND MOLECULAR LIFE SCIENCESIF6.22019-04-0521OAAI
The detection of EGFR mutations in liquid biopsy by allele-specific qPCR - the comparative evaluation of two common diagnostic testsEUROPEAN RESPIRATORY JOURNALIF212018-11-190PRE
The allelic frequency for S and Z mutations in the SERPINA1 gene in NSCLC patients from PolandEUROPEAN RESPIRATORY JOURNALIF212017-12-060PRE
LSC-2017-The serum levels of alpha-1 antitrypsin are strongly associated with its local production by NSCLC tumor cellsEUROPEAN RESPIRATORY JOURNALIF212017-12-060PRE
miRNAs as Biomarkers and Therapeutic Targets in Non-Small Cell Lung Cancer: Current PerspectivesTARGETED ONCOLOGYIF42017-02-2796OAAI
Alveolar lymphocytes (AL) in healthy individuals are mostly effector T cells. The flow cytometry (FC) lesson for interstitial lung diseases (ILD) evaluationEUROPEAN RESPIRATORY JOURNALIF212016-11-080PRE
Plasma cell-free DNA levels and integrity in patients with chest radiological findings: NSCLC versus benign lung nodulesCANCER LETTERSIF10.12016-05-0135PREAI
Inhibition of the effect of epidermal growth factor (EGF) on lung cancer cells. The use of plasmids encoding specific siRNA moleculesEUROPEAN RESPIRATORY JOURNALIF212015-10-301PRE
The evaluation of biological and clinical significance of alpha-1 antitrypsin in non-small cell lung cancerEUROPEAN RESPIRATORY JOURNALIF212015-10-300PRE
Studies on hepatocyte growth factor (HGF) in bronchoalveolar lavage (BAL) do not support the concept on its antifibrotic properties in idiopathic pulmonary fibrosis (IPF)EUROPEAN RESPIRATORY JOURNALIF212015-10-300PRE